Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Getz

Showing results (271-280 of 397) with videos related to

Pageof 40
Sort By:
Nature Genetics|August 14, 2019
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancerSahar Nissim, Ignaty Leshchiner, Joseph D Mancias, et al.
Nature Medicine|May 20, 2014
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicineEliezer M Van Allen, Nikhil Wagle, Petar Stojanov, et al.
Science (New York, N.Y.)|April 23, 2021
Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accidentMeredith Yeager, Mitchell J Machiela, Prachi Kothiyal, et al.
Nature Cancer|August 8, 2025
SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursorsElizabeth D Lightbody, Romanos Sklavenitis-Pistofidis, Ting Wu, et al.
Acta Neuropathologica Communications|January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivationGanesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.
Nature Communications|October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentationMoshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2020
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease ProgressionMark Bustoros, Romanos Sklavenitis-Pistofidis, Jihye Park, et al.
Nature Biotechnology|April 19, 2016
Characterizing genomic alterations in cancer by complementary functional associationsJong Wook Kim, Olga B Botvinnik, Omar Abudayyeh, et al.
Nature Genetics|March 26, 2013
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexityAustin M Dulak, Petar Stojanov, Shouyong Peng, et al.
Cancer Discovery|July 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung CancerAshish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, et al.
Pageof 40

Showing results (271-280 of 397) with videos related to

Sort By:
Pageof 40
Nature Genetics|August 14, 2019
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancerSahar Nissim, Ignaty Leshchiner, Joseph D Mancias, et al.
Nature Medicine|May 20, 2014
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicineEliezer M Van Allen, Nikhil Wagle, Petar Stojanov, et al.
Science (New York, N.Y.)|April 23, 2021
Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accidentMeredith Yeager, Mitchell J Machiela, Prachi Kothiyal, et al.
Nature Cancer|August 8, 2025
SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursorsElizabeth D Lightbody, Romanos Sklavenitis-Pistofidis, Ting Wu, et al.
Acta Neuropathologica Communications|January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivationGanesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.
Nature Communications|October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentationMoshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2020
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease ProgressionMark Bustoros, Romanos Sklavenitis-Pistofidis, Jihye Park, et al.
Nature Biotechnology|April 19, 2016
Characterizing genomic alterations in cancer by complementary functional associationsJong Wook Kim, Olga B Botvinnik, Omar Abudayyeh, et al.
Nature Genetics|March 26, 2013
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexityAustin M Dulak, Petar Stojanov, Shouyong Peng, et al.
Cancer Discovery|July 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung CancerAshish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, et al.
Pageof 40